FY26 Lab Consolidation for Coagulation CPRR Effort

This document outlines the technical requirements for coagulation analyzers and related services for military treatment facilities (MTFs). Key requirements include new, FDA-approved equipment capable of bidirectional interfacing with existing electronic health records (EHR) and Laboratory Information Management Systems (LIMS). The contractor must provide all reagents, consumables, maintenance (preventive and repair), and training for government personnel. Additionally, the solution must include peripheral equipment like printers and UPS units. The contractor is responsible for delivery, installation, and removal of equipment, ensuring seamless transition and maintaining a 95% uptime. The document also details specific requirements for waste disposal, data accessibility (ODBC-compliant, unencrypted format), and emergency supply delivery within 24 hours. The contractor must accommodate potential volume surges of up to 50% and adhere to strict performance and acceptance testing standards, with an implementation period not exceeding 60 days. Comprehensive service and maintenance, including 24/7 technical assistance and 24-hour on-site response for repairs, are mandatory.

Amendment 0001 to Combined Synopsis and Solicitation HT941026Q2004 revises the due dates for questions and quotations related to the FY26 HCD-W Coagulation Analyzer Cost Per Reportable Results. This amendment, dated May 20, 2026, requires that acknowledgement and any resultant amended quotation be submitted using the CSS Coagulation Attachment 3 Quote Sheet. All other terms and conditions of the original CSS remain unchanged. The amendment is signed by Contracting Officer Cha-on Gordon.

This Request for Quotation (RFQ) HT941026Q2004, issued by the government, seeks proposals for a cost per reportable result (CPRR) contract for coagulation analyzers. These analyzers will support eleven military treatment facilities (MTFs) across various networks, handling a total of 104,437 tests annually. The acquisition falls under NAICS Code 334516 (Analytical Laboratory Instrument Manufacturing) and PSC 6550 (In-Vitro Diagnostic Substances, Reagents, Test Kits and Sets). It is an unrestricted procurement, open to full and open competition. Key evaluation factors include Technical capability, Past Performance, Information Assurance, and Price, with non-price factors being more important than price. Quoters must provide specific documentation, including a Technical Submission Form, CyberLOG-ICS Medical Device and Equipment Risk Assessment (MDERA) Questionnaire, and a Quote Sheet. Submissions are due by June 9, 2026, at 1:00 p.m. Pacific, with questions accepted until May 28, 2026. Contractors must adhere to various FAR and DFARS provisions, including those related to the Defense Biometric Identification System (DBIDS) for access control.

This government Request for Quote (RFQ) (Reference Number: HT941026Q2004) outlines the requirements for coagulation CPRR services for the DHA Healthcare Contracting Division - West. The document details a base period (October 1, 2026 – September 30, 2027) and four option periods, extending services through March 31, 2032. Services are to be provided across various Military Treatment Facilities (MTFs) in multiple networks including Pacific Rim, Indo Pacific, Continental, Central, and West. The RFQ includes a comprehensive list of coagulation tests required, such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Lupus Anticoagulant, Fibrinogen, D-Dimer, Heparin, DIC Panel, Patient Thrombin Time, Mixing Studies, Reptilase Time, Factor V, VII, VIII, IX, X, XI, XII Assays, Antithrombin III, Factor XIII Assay, Von Willebrand Factor Antigen, and Platelet Aggregation Test, along with their estimated annual test volumes per facility. The document also provides sections for offeror information, amendment acknowledgments, agreement to terms, payment terms, and a total evaluated price.

This Pre-Solicitation document contains questions and answers regarding RFP HT941026Q2004, focusing on clarifications for a government contract. Key areas addressed include proposal and option period due dates, site start dates, and transition timelines, with a goal for all Medical Treatment Facilities (MTFs) to be live by October 1, 2027. It details quality control and specialty testing procedures, pricing strategies (Cost Per Reportable Result vs. By the Box), and mandatory versus preferred site-specific requirements. The document also clarifies technical aspects like analyzer size, surge capacity, and cybersecurity requirements, including Country of Origin reporting for hardware and software. Evaluation criteria, invoicing, and updates to attachments for accurate information are also covered, highlighting the government’s intent for a “Best Value Tradeoff” award.

This Statement of Work outlines the requirements for a Cost-Per-Reportable Result (CPRR) contract for coagulation analyzers, reagents, and consumables for twelve military treatment facilities (MTFs). The contract includes a one-year base period and four option years, covering all reagents, consumables, maintenance, training, delivery, installation, and removal of equipment. All equipment must be new, FDA-approved, and capable of bidirectional interfacing with existing electronic health records (EHR) and military Laboratory Information Management Systems (LIMS). The contractor is responsible for maintaining a 95% uptime rate for all analyzers, providing emergency repairs within 48 hours, and continuously stocking supplies. The contract also details requirements for hazardous waste management, data accessibility, and comprehensive training for government personnel.

No AI summary available for this file.

This government file details the requirements for Network Analyzer Quantities and related equipment for various medical treatment facilities (MTFs) across Indo Pacific, Pacific Rim, Central, and West regions. The document specifies quantities, anticipated start dates of deliveries (ranging from October 2026 to September 2027), maximum space dimensions, and power requirements for analyzer equipment such as STA R Max, STA Compact Max, CS 2500, and CS 5100. It also outlines site-specific requirements, including the need for fully automated benchtop devices capable of clot detection, automatic dilution, plasma sample processing, and barcode identification. Several MTFs, including Madigan Army Medical Center and Naval Medical Center San Diego, are listed with their addresses and projected monthly test volumes for various assays like Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen, and D-Dimer. A key requirement is that new equipment must not exceed defined maximum space dimensions and should not require external water sources or drains. The document also addresses the ability of MTFs to accommodate new equipment while old equipment is still present, indicating that this is dependent on the size of the new equipment and overall laboratory layout.

The Medical Device and Equipment Risk Assessment (MDERA) Version 6.4.1 is a crucial questionnaire for vendors to ensure security compliance of medical systems/devices with US Federal Government, Department of Defense (DoD), and Defense Health Agency (DHA) policies. It is a pre-procurement selection tool for the Risk Management Framework (RMF) Authorization process. Failure to provide accurate information can lead to ineligibility for purchase or contract cancellation. The MDERA assesses data processing capabilities, security posture, and compliance with confidentiality, integrity, and availability principles to determine the effort required for an RMF Assessment. The document outlines sections for vendor and technical point of contact information, system identification (including technical and regulatory details, mode of operation, cloud offerings, and interfaces), technical information (hardware, operating systems, applications, vulnerability management, remote access, wireless capabilities, and mass storage), and data processing capabilities (ePHI/PII handling, storage, input, workflow, and encryption). The MDERA is applicable to both regulated and non-regulated medical technologies.

This Statement of Work outlines the requirements for a Cost-Per-Reportable Result (CPRR) contract for coagulation analyzers to support eleven military treatment facilities (MTFs), with the option to add more. The CPRR price will cover a base year and four option years, including all reagents, consumables, maintenance, training, delivery, installation, and removal of new, FDA-approved, and interface-capable equipment. The contractor must provide continuous inventory, manage hazardous waste, and ensure data accessibility. Analyzers should allow for random access, continuous testing, and flagging, with specific features like automatic dilutions and onboard reagent management. The contract mandates a 60-day implementation period and a 95% equipment uptime rate. The contractor is responsible for upgrades, ancillary equipment, and submitting detailed service reports, while retaining ownership of the equipment. Strict compliance with cybersecurity and patient information confidentiality is also required.

This is a combined synopsis/solicitation (RFQ) for a cost-per-reportable-result (CPRR) contract for coagulation analyzers and associated services to support 11 military treatment facilities (MTFs) across the US, with a total of 18 analyzers and an estimated 99,299 tests per year. The acquisition, under NAICS Code 334516, is unrestricted, inviting full and open competition. Key evaluation factors are Technical, Past Performance, Information Assurance, and Price, with non-price factors being more important than price. Quoters must be authorized dealers/manufacturers, submit technical and pricing forms, and address information assurance requirements, including compliance with the DoD Risk Management Framework (RMF). Quotes are due by April 30, 2026, at 1:00 p.m. Pacific.

The Statement of Work outlines a Cost-Per-Reportable Result (CPRR) contract for coagulation analyzers to support 11 military treatment facilities (MTFs), with the option to add more. The contract includes a base year and four option years, covering all reagents, consumables, maintenance, training, delivery, installation, and peripheral equipment. Key requirements include new, FDA-approved equipment capable of bidirectional interfacing with existing electronic health records (EHR) and Laboratory Information Management Systems (LIMS), maintaining a 95% uptime, and supporting a 50% surge in volume. The contractor is responsible for installation, waste disposal, data accessibility, continuous supply inventory, and emergency repairs within 24-48 hours. The government will only pay for actual tests received, and ownership of equipment remains with the contractor, who is also responsible for its removal and data sanitization upon contract expiration. All work must comply with DoD Cybersecurity/Risk Management Framework requirements.

This document outlines requirements for Network Analyzer equipment for various military treatment facilities (MTFs) across Indo-Pacific, Pacific Rim, Central, and West regions. It details the quantity of analyzers needed per location, anticipated start dates for deliveries, and specific requirements for each MTF. Key information includes maximum space dimensions, power requirements (mostly 120V, 60Hz), and whether the MTF has room for new equipment while old equipment is still present. Many MTFs require fully automated benchtop analyzers capable of clot detection, automatic dilution, processing plasma samples, and positive patient sample identification via barcodes. Some sites have specific requests for onboard QC and historical patient databases, and lot-to-lot calibration support. The document also lists individual tests anticipated for DIC panels (PT, aPPT, Fibrinogen, D-Dimer) and whether they are included in other test counts or billed separately. Most labs have access to reagent-grade rinse water. Various coagulation tests (PT, aPPT, Fibrinogen, D-Dimer, Heparin, INR, Lupus Anticoagulant, Factor VIII Assay, DIC Panel, Heparin (Low Molecular Weight), Patient Thrombin Time, Mixing Studies, Reptilase Time, Factor V, VII, IX, X, XI, Antithrombin III, Von Willebrand Factor Antigen, and Factor II Assays) and their anticipated annual volumes are provided for each MTF.

This document outlines the technical requirements for coagulation analyzers under a CPRR contract for military treatment facilities. Key requirements include new equipment, comprehensive reagents and supplies, maintenance, training for up to 10 users and super-users, delivery, installation, and removal of equipment including peripherals like UPS units with 1-hour capability. All equipment and reagents must be FDA-approved, capable of performing tests without third-party reagents, and interface bidirectionally with the electronic health record (EHR) and Military Laboratory Information Management System (LIMS) within 30 days of installation. The system must automatically recover from interface downtime without manual intervention. The contract requires robust reporting capabilities, continuous inventory of consumables, and emergency supply delivery within 24 hours. Analyzers must offer random access, continuous testing, flagging capabilities, automatic dilutions, on-board reagent storage, shelf-life management, QC lockout, and reagent sequestering. The contractor is responsible for installation, site preparation, hazardous waste management according to CFR Title 40, data accessibility in an ODBC-compliant, unencrypted format, and providing a full data dictionary. The contract also covers replacement parts, software updates, emergency repairs with a 2-hour call-back and 24-hour on-site response, and equipment repair within 48 hours. A 60-day implementation plan is required, with an acceptance period ending after 30 consecutive days of 95% operational effectiveness, which must be maintained monthly. The contractor must adhere to all terms, including government and contractor responsibilities, reporting, ownership, and information assurance.

This document is an RFQ (Request for Quote) identified as HT941026Q2004, issued by the DHA Healthcare Contracting Division - West. The requirement, DHA HCD-W Coagulation CPRR, pertains to coagulation testing services. The RFQ includes a detailed quote sheet listing various coagulation tests such as Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), Fibrinogen, D-Dimer, and others, along with their estimated annual test counts. The document outlines pricing for a base period (10/01/2026 - 09/30/2027), four option periods extending through 09/30/2030, and a 6-month extension option from 10/01/2031 - 03/31/2032. Offerors are required to agree to all terms, conditions, and provisions, acknowledge receipt of any amendments, and hold prices firm for 60 calendar days. The total evaluated price is to be calculated based on the base period and four options.